Tandlægeselskabet Godt Smil Taastrup ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 0.0% 7.3% 13.3% 10.8%  
Credit score (0-100)  0 0 33 16 23  
Credit rating  N/A N/A BBB BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 2,725 4,955 6,648  
EBITDA  0.0 0.0 -852 -213 761  
EBIT  0.0 0.0 -1,517 -1,176 -225  
Pre-tax profit (PTP)  0.0 0.0 -1,706.7 -1,519.3 -673.1  
Net earnings  0.0 0.0 -1,326.0 -1,177.4 -522.0  
Pre-tax profit without non-rec. items  0.0 0.0 -1,707 -1,519 -673  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 5,453 5,917 5,261  
Shareholders equity total  0.0 0.0 -262 -1,440 -1,962  
Interest-bearing liabilities  0.0 0.0 7,212 3,558 3,251  
Balance sheet total (assets)  0.0 0.0 7,372 8,248 7,661  

Net Debt  0.0 0.0 6,996 3,305 3,070  
 
See the entire balance sheet

Volume 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 2,725 4,955 6,648  
Gross profit growth  0.0% 0.0% 0.0% 81.9% 34.2%  
Employees  0 0 6 9 8  
Employee growth %  0.0% 0.0% 0.0% 50.0% -11.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 7,372 8,248 7,661  
Balance sheet change%  0.0% 0.0% 0.0% 11.9% -7.1%  
Added value  0.0 0.0 -852.1 -510.9 761.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 4,788 -498 -1,643  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -55.7% -23.7% -3.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -19.4% -13.1% -2.0%  
ROI %  0.0% 0.0% -20.5% -21.1% -5.8%  
ROE %  0.0% 0.0% -18.0% -15.1% -6.6%  

Solidity 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 0.0% -3.5% -15.0% -20.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -821.1% -1,551.2% 403.3%  
Gearing %  0.0% 0.0% -2,750.5% -247.2% -165.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 6.3% 7.1% 14.0%  

Liquidity 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.0 0.2 0.2 0.2  
Current Ratio  0.0 0.0 0.3 0.3 0.3  
Cash and cash equivalent  0.0 0.0 215.8 253.0 181.2  

Capital use efficiency 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -2,976.5 -3,894.4 -4,234.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -142 -57 95  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -142 -24 95  
EBIT / employee  0 0 -253 -131 -28  
Net earnings / employee  0 0 -221 -131 -65